Clinical Study

Efficacy of Single-Pill Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial

Figure 3

ORs (95% CI) of SPC T80/H25 versus T80 for proportion of patients with seated trough cuff SBP reduction (a) >30 mm Hg and (b) >40 mm Hg at Week 7 by patient subgroup (FAS). BMI: body mass index; CHD, coronary heart disease; CI: confidence interval; eGFR, estimated glomerular filtration rate; FAS: full analysis set; H25: hydrochlorothiazide 25 mg; OR: odds ratio; SBP: systolic blood pressure; SPC, single-pill combination; T80: telmisartan 80 mg.
749830.fig.003a
(a)
749830.fig.003b
(b)